PHVS Stock Analysis: Buy, Sell, or Hold?
PHVS - Pharvaris N.V. Ordinary Shares
$32.62
-1.26 (-3.72%)
▼
5d:
-4.54%
30d:
-3.92%
90d:
+5.19%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When PHVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PHVS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: PHVS shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: PHVS is currently trading at $32.62, which is considered oversold relative to its 30-day fair value range of $33.34 to $35.04.
Technical Outlook: Technically, PHVS is in a strong uptrend. The price is currently testing key support at $32.00. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.87 (+46.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PHVS is in a strong uptrend. The price is currently testing key support at $32.00. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $47.87 (+46.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$33.34 -
$35.04
Company Quality Score
59/100
(HOLD)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
75.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 46.7% below Wall St target ($47.87)
Trading Range Analysis
30-Day Trading Range
$33.34 -
$35.04
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.88
(15.0%)
Support & Resistance Levels
Support Level
$32.00
Resistance Level
$35.54
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.37
Wall Street Target
$47.87
(+46.7%)
Share & Embed Analysis
Last updated: August 03, 2026 2:22 AM ET
Data refreshes hourly during market hours. Next update: 3:22 AM
Data refreshes hourly during market hours. Next update: 3:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHVS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Anne Lesage
SELL
100 shares
2026-04-23
Johannes Gerardus Chri S…
SELL
100 shares
2026-04-23
Peng Lu
SELL
100 shares
2026-04-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 58 HOLD |
Advanced PHVS Option Strategies
Professional options setups generated by AI based on today's PHVS price and gamma walls.
